Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic

por Torres, Tiago, Puig, Luis
Publicado 2020

IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications

por Iznardo, Helena, Puig, Luís
Publicado 2022

Tyk2 Targeting in Immune-Mediated Inflammatory Diseases

por Rusiñol, Lluís, Puig, Luis
Publicado 2023

Omnidirectional Structured Light in a Flexible Configuration

por Paniagua, Carmen, Puig, Luis, Guerrero, José J.
Publicado 2013

Deucravacitinib for the Treatment of Psoriatic Disease

por Lé, Ana Maria, Puig, Luis, Torres, Tiago
Publicado 2022

Predictors of biologic treatment of psoriasis: a non-interventional study

por Puig, Luis, Fan, Tao, Ding, Qian, Smith, Nancy E
Publicado 2014

Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab

por Lambert, Jo, Hansen, Jes Birger, Sohrt, Anne, Puig, Luis
Publicado 2021

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review

por Girolomoni, Giampiero, Savage, Laura, Gisondi, Paolo, Svensson, Åke, Mahé, Emmanuel, Augustin, Matthias, Puig, Luis
Publicado 2023

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment

por Rivera-Díaz, Raquel, Daudén, Esteban, Carrascosa, José Manuel, Cueva, Pablo de la, Puig, Luis
Publicado 2023

Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model

por Papp, Kim A., Soliman, Ahmed M., Done, Nicolae, Carley, Christopher, Lemus Wirtz, Esteban, Puig, Luis
Publicado 2021

Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?

por Speeckaert, Reinhart, Lambert, Jo, Puig, Luis, Speeckaert, Marijn, Lapeere, Hilde, De Schepper, Sofie, van Geel, Nanja
Publicado 2021

Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis

por Armstrong, April W., Soliman, Ahmed M., Betts, Keith A., Wang, Yan, Gao, Yawen, Puig, Luis, Augustin, Matthias
Publicado 2021

Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis

por Armstrong, April W., Soliman, Ahmed M., Betts, Keith A., Wang, Yan, Gao, Yawen, Stakias, Vassilis, Puig, Luis
Publicado 2021

A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis

por Armstrong, April W., Soliman, Ahmed M., Betts, Keith A., Wang, Yan, Gao, Yawen, Stakias, Vassilis, Puig, Luis
Publicado 2022

Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials

por Chabra, Sanjay, Gill, B. J., Gallo, Gaia, Zhu, Danting, Pitou, Celine, Payne, Christopher D., Accioly, Ana, Puig, Luis
Publicado 2022

Nomenclature and clinical phenotypes of atopic dermatitis

por Girolomoni, Giampiero, de Bruin-Weller, Marjolein, Aoki, Valeria, Kabashima, Kenji, Deleuran, Mette, Puig, Luis, Bansal, Ashish, Rossi, Ana B.
Publicado 2021

PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries

por LANGENBRUCH, Anna, MOHR, Nicole, ANDREES, Valerie, KESSENS, Ihno, REICH, Adam, CZARNECKA-OPERACZ, Magdalena, PUIG, Luis, DAUDEN, Esteban, IVERSEN, Lars, AUGUSTIN, Matthias
Publicado 2023

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

por Egeberg, Alexander, Merola, Joseph F., Schäkel, Knut, Puig, Luis, Mahar, Patrick D., Wang, Isabella Yali, Pavo, Imre, Schuster, Christopher, Griffiths, Christopher E. M.
Publicado 2023

Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

por Egeberg, Alexander, Merola, Joseph F., Schäkel, Knut, Puig, Luis, Mahar, Patrick D., Wang, Isabella Yali, Pavo, Imre, Schuster, Christopher, Griffiths, Christopher E. M.
Publicado 2023

Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

por Adsit, Sandra, Zaldivar, Enrique Rivas, Sofen, Howard, Dei-Cas, Ignacio, Maldonado-García, César, Peñaranda, Elkin O., Puig, Luís, Meng, Xiangyi, Fox, Todd, Guana, Adriana
Publicado 2017